Hepatitis delta: the rediscovery.
暂无分享,去创建一个
[1] S. Alavian,et al. Prevalence of Hepatitis D in the Eastern Mediterranean Region: Systematic Review and Meta Analysis , 2013, Hepatitis monthly.
[2] M. Rizzetto,et al. Epidemiology of Hepatitis D , 2012, Seminars in Liver Disease.
[3] Ricardo Flores,et al. Viroids and Hepatitis Delta Virus , 2012, Seminars in Liver Disease.
[4] F. Le Gal,et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania , 2012, Journal of medical virology.
[5] C. Leen,et al. Hepatitis delta in HIV-infected individuals in Europe , 2011, AIDS.
[6] W. Shin,et al. Prevalence and clinical significance of hepatitis D virus co‐infection in patients with chronic hepatitis B in Korea , 2011, Journal of medical virology.
[7] N. Gozel,et al. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider , 2011, Journal of viral hepatitis.
[8] G. Mihăescu,et al. Hepatitis B, C and D coinfection in HIV-infected patients: prevalence and progress. , 2011, Roumanian archives of microbiology and immunology.
[9] M. Buti,et al. Clinical outcome of acute and chronic hepatitis delta over time: a long‐term follow‐up study , 2011, Journal of viral hepatitis.
[10] D. Genné,et al. Hepatitis delta in Switzerland: a silent epidemic. , 2011, Swiss medical weekly.
[11] N. Dominique,et al. High prevalence and predominance of Hepatitis D genotype 1 infection in Cameroon , 2011 .
[12] R. Njouom,et al. High Prevalence and Predominance of Hepatitis Delta Virus Genotype 1 Infection in Cameroon , 2011, Journal of Clinical Microbiology.
[13] A. Khalilian,et al. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. , 2010, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[14] J. Ward,et al. Hepatitis delta: seek and ye shall find. , 2010, The Journal of infectious diseases.
[15] L. Kucirka,et al. Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. , 2010, The Journal of infectious diseases.
[16] M. Rizzetto. Delta Hepatitis: Forgotten, but Not Gone , 2010 .
[17] B. McMahon,et al. Hepatitis D outbreak among children in a hepatitis B hyper‐endemic settlement in Greenland , 2010, Journal of viral hepatitis.
[18] M. Voiculescu,et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. , 2010, Journal of gastrointestinal and liver diseases : JGLD.
[19] Z. Abbas,et al. Hepatitis D: Scenario in the Asia-Pacific region. , 2010, World journal of gastroenterology.
[20] E. Hajiani,et al. Seroprevalence of delta hepatitis in patients with chronic hepatitis B and its clinical impact in Khuzestan Province, Southwest Iran. , 2009 .
[21] H. Tillmann,et al. Virological and clinical characteristics of delta hepatitis in Central Europe , 2009, Journal of viral hepatitis.
[22] E. Sagnelli,et al. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study , 2009, Journal of medical virology.
[23] S. Nwokediuko,et al. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. , 2009, Nigerian journal of clinical practice.
[24] Z. Abbas,et al. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. , 2009, JPMA. The Journal of the Pakistan Medical Association.
[25] M. Kazanji,et al. Prevalence and Molecular Diversity of Hepatitis B Virus and Hepatitis Delta Virus in Urban and Rural Populations in Northern Gabon in Central Africa , 2009, Journal of Clinical Microbiology.
[26] M. Rizzetto. Hepatitis D: thirty years after. , 2009, Journal of hepatology.
[27] C. Yurdaydın,et al. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta‐analysis , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[28] M. Sugiyama,et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan , 2008, Journal of medical virology.
[29] M. Hussain,et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London , 2008, Journal of medical virology.
[30] Y. Yıldırım,et al. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: leading role of HBV in 505 cases. , 2007, Hepato-gastroenterology.
[31] M. Manns,et al. Hepatitis D virus infection—Not a vanishing disease in Europe! , 2007, Hepatology.
[32] A. Sharara,et al. Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon , 2006, Epidemiology and Infection.
[33] R. Uehara,et al. Hepatitis delta virus infection in mongolia: analyses of geographic distribution, risk factors, and disease severity. , 2006, The American journal of tropical medicine and hygiene.
[34] T. Nishizawa,et al. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia , 2006, Journal of medical virology.
[35] B. Bell,et al. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users , 2005, Journal of Urban Health.
[36] J. Taylor,et al. Structure and replication of hepatitis delta virus RNA. , 2006, Current topics in microbiology and immunology.
[37] S. Alavian,et al. Hepatitis D Virus Infection; Iran, Middle East and Central Asia , 2005 .
[38] E. Sagnelli,et al. Chronic hepatitis D: A vanishing disease? An Italian multicenter study , 2000, Hepatology.
[39] A. Kidd,et al. Recent High Incidence of Fulminant Hepatitis in Samara, Russia: Molecular Analysis of Prevailing Hepatitis B and D Virus Strains , 2000, Journal of Clinical Microbiology.
[40] A. Andriulli,et al. Changing pattern of chronic hepatitis D in Southern Europe. , 1999, Gastroenterology.
[41] F. Chang,et al. Decreasing hepatitis D virus infection in Taiwan: An analysis of contributory factors , 1997, Journal of gastroenterology and hepatology.
[42] E. Sagnelli,et al. Decrease in HDV endemicity in Italy. , 1997, Journal of hepatology.
[43] M. Rizzetto,et al. Advances in hepatitis D virus biology and disease. , 1994, Progress in liver diseases.
[44] M. Rizzetto,et al. Hepatitis delta virus infection in the world: Epidemiological patterns and clinical expression , 1992 .
[45] M. Darwish,et al. Hepatitis B & D viral infections among schistosomal patients in Egypt. , 1992, The Journal of the Egyptian Public Health Association.
[46] M. Darwish,et al. Delta virus infection in Egypt. , 1992, The Journal of the Egyptian Public Health Association.
[47] A. Aceti,et al. High prevalence of anti-hepatitis delta virus antibody in chronic liver disease in Somalia. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[48] M. Rizzetto,et al. Epidemiology of hepatitis delta virus: overview. , 1991, Progress in clinical and biological research.
[49] K. Hyams,et al. A seroepidemiological survey of viral hepatitis in the Yemen Arab Republic. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[50] M. Rizzetto,et al. Hepatitis delta virus as a global health problem. , 1990, Vaccine.
[51] J. Poss. Hepatitis D virus infection. , 1989, The Nurse practitioner.
[52] A. Grilli,et al. Sero-epidemiology of hepatitis delta virus infection in Somalia. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[53] K. Hyams,et al. Epidemiology of hepatitis B in the Gezira region of Sudan. , 1989, The American journal of tropical medicine and hygiene.
[54] N. Constantine,et al. Ethnic differences in the prevalence of hepatitis delta agent in Djibouti. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[55] M. Kreek,et al. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. , 1988, The Journal of infectious diseases.
[56] R. Lal,et al. An epidemic of hepatitis D in the foothills of the Himalayas in south Kashmir. , 1988, Journal of hepatology.
[57] S. Hadler,et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. , 1987, The New England journal of medicine.
[58] H. Margolis,et al. The epidemiology and clinical outcome of hepatitis D virus (delta) infection in Jordan , 1987, Hepatology.
[59] C. Trépo,et al. Studies on the role of HDV in an outbreak of fulminant hepatitis in Bangui (Central African Republic). , 1987, Progress in clinical and biological research.
[60] I. Mushahwar,et al. Delta agent infection in Riyadh, Saudi Arabia. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[61] S. Hadler,et al. Epidemiologic aspects of Santa Marta hepatitis over a 40‐year period , 1986, Hepatology.
[62] P. Tukei,et al. Hepatitis delta virus infection in Kenya. Its geographic and tribal distribution. , 1986, American journal of epidemiology.
[63] D. Brettler,et al. Epidemiology and clinical impact of hepatitis D virus (delta) infection , 1985, Hepatology.
[64] R. Purcell,et al. Hepatitis B Markers in United States Drug Addicts with Special Emphasis on the Delta Hepatitis Virus , 1984, Hepatology.
[65] S. Hadler,et al. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. , 1984, Annals of internal medicine.
[66] M. Rizzetto,et al. The Delta Agent , 2007, Hepatology.
[67] M. Rizzetto,et al. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. , 1983, American journal of epidemiology.
[68] H. Greenberg. Progress in Liver Disease , 1970 .
[69] M. Koffler. Epidemiology of hepatitis. , 1965, Lancet.